Press Releases

Cubist Pharmaceuticals Inc. today announced the initiation of Phase 3 efficacy studies of bevenopran (previously known as CB-5945) in patients with chronic non-cancer pain and opioid-induced constipation (OIC). The Phase 3 program ASCENT includes three...

Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2...

Impax Laboratories Inc. today announced that it is commencing shipment of authorized generic TRILIPIX® (fenofibric acid) delayed release capsules 45 mg and 135 mg through Global Pharmaceuticals Impax’s generics division. Under the terms of a...

Tetrahedron, designing and developing rare natural and synthetic antioxidants for the health nutrition, dermocosmetics and pharmacy sectors, today announces that Selisseo(R) has received marketing authorization (MA) from the European Commission for use in animal nutrition for all animal species....

Medivir AB (STO:MVIR-B) today announced that the company has signed an agreement to sell its wholly owned subsidiary Cross Pharma AB to Unimedic AB a subsidiary of the Swedish listed company MedCap AB. The intention is to close the...

Quintiles has been named “Britain’s Healthiest Large Company” in the first survey of its kind to identify organizations in Britain with outstanding employee health and wellness programs. Quintiles also received top honors as overall healthiest...

The American Association of Clinical Endocrinologists (AACE) applauds the American Medical Association (AMA) House of Delegates for its action today to approve a resolution recognizing obesity as a disease state requiring a range of interventions to advance obesity treatment...